Vimarsana
Biggest News Aggregation in the World

Chappell Ingram News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chappell Ingram. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chappell Ingram Today - Breaking & Trending Today

Illinois Delta-8 Regulation Bill Stalls in House of Representatives - Vimarsana News

Illinois Delta-8 Regulation Bill Stalls in House of Representatives

The Illinois House of Representatives has adjourned for the summer without passing legislation to regulate hemp-derived cannabinoids.

Illinois bill regulating delta-8, other hemp products stalls in House - Vimarsana News

Illinois bill regulating delta-8, other hemp products stalls in House

A bill that would've banned sales of pot-like delta-8 products sailed through the Illinois Senate, but never made it to the floor of the state House. That means the mind-altering products will be unchecked for yet another summer in Chicago and beyond.

Illinois officials welcome federal government's move to reclassify cannabis - Vimarsana News

Illinois officials welcome federal government's move to reclassify cannabis

The Biden administration on Thursday officially proposed reclassifying cannabis from a Schedule I drug to a Schedule III on the federal list of controlled substances.

Justice Department submits rule to re-schedule cannabis - Vimarsana News

Justice Department submits rule to re-schedule cannabis

(The Center Square) – The Justice Department announced Thursday that it had submitted a rule that would ease restrictions on cannabis, but the move falls short of the full legalization

Local cannabis industry leaders say move to reclassify weed will benefit businesses, customers - Vimarsana News

Local cannabis industry leaders say move to reclassify weed will benefit businesses, customers

The move would in part ease tax burdens on pot shops, which are currently prohibited from deducting expenses from income associated with Schedule I or II substances. Savings on those costs could be passed on to customers, industry leaders said.